# Insulin Resistance Study

> **NCT00614757** · NA · SUSPENDED · sponsor: **Midwest Biomedical Research Foundation** · enrollment: 121 (actual)

## Conditions studied

- Insulin Resistance
- Metabolic Syndrome x

## Interventions

- **DRUG:** N-acetylcysteine 20% 4ml
- **DRUG:** N-acetylcysteine 20% in 4 ml

## Key facts

- **NCT ID:** NCT00614757
- **Lead sponsor:** Midwest Biomedical Research Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2005-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2012-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00614757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00614757, "Insulin Resistance Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00614757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*